These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4867515)

  • 61. [Use of Visken-15 for treating hypertension].
    Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA
    Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 63. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.
    Tarazi RC; Dustan HP
    Am J Cardiol; 1972 May; 29(5):633-40. PubMed ID: 5021493
    [No Abstract]   [Full Text] [Related]  

  • 64. Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.
    Stenson RE; Flamm MD; Harrison DC; Hancock EW
    Am J Cardiol; 1973 Jun; 31(6):763-73. PubMed ID: 4735938
    [No Abstract]   [Full Text] [Related]  

  • 65. I1 agents: a new approach to the treatment of hypertension.
    Dubar M; Pillion G
    Ann N Y Acad Sci; 1995 Jul; 763():642-58. PubMed ID: 7677384
    [No Abstract]   [Full Text] [Related]  

  • 66. The drug treatment of hypertension.
    Bulpitt CJ; Dollery CT
    Practitioner; 1971 Jul; 207(237):43-51. PubMed ID: 4397593
    [No Abstract]   [Full Text] [Related]  

  • 67. [New, in Austria registered specialty drugs. Normoxin (moxonidine)].
    Kögler H; Raneburger J
    Wien Klin Wochenschr; 1993; 105(3):94-6. PubMed ID: 8447129
    [No Abstract]   [Full Text] [Related]  

  • 68. Hypotensive effects of intravenous dichlorphenylaminoimidazoline.
    Kühns K; Oloffs J; Pohlmann F
    Ger Med Mon; 1968 Oct; 13(10):483-5. PubMed ID: 4884403
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
    Putzeys MR; Hoobler SW
    Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
    [No Abstract]   [Full Text] [Related]  

  • 70. Difficult-to-control hypertension: effects of olmesartan-based combination therapies.
    de la Sierra A
    J Hypertens; 2013 Mar; 31 Suppl 1():S1-2. PubMed ID: 23389082
    [No Abstract]   [Full Text] [Related]  

  • 71. A three-phase clinical evaluation of prazosin.
    Smith IS; Fernandes M; Kim KE; Swartz C; Onesti G
    Postgrad Med; 1975 Nov; Spec No():53-60. PubMed ID: 1105485
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect.
    Amery AK; Bossaert H; Fagard RH; Verstraete M
    Acta Cardiol; 1972; 21(1):82-99. PubMed ID: 4553878
    [No Abstract]   [Full Text] [Related]  

  • 73. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 74. [Emergency prehospital care for uncomplicated hypertensive crisis].
    El'kis IS; Borisova VA; Ovasapian IuA; Sidorov AM
    Ter Arkh; 2006; 78(1):20-3. PubMed ID: 16512440
    [No Abstract]   [Full Text] [Related]  

  • 75. [Changed guidelines of the German High Blood Pressure League. AT(1) blocker in the first league now].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494603
    [No Abstract]   [Full Text] [Related]  

  • 76. Tribenzor for hypertension.
    Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Trial of a new hypotensive drug--clonidine ("catapres").
    Trinker FR; Barnett AJ
    Med J Aust; 1970 Oct; 2(15):975-8. PubMed ID: 4920641
    [No Abstract]   [Full Text] [Related]  

  • 78. Pharmacodynamic activity of intravenous E-3174, an angiotensin II antagonist, in patients with essential hypertension.
    Sweet CS; Bradstreet DC; Berman RS; Jallard N; Saenz A; Weidler DJ
    Am J Hypertens; 1994 Dec; 7(12):1035-40. PubMed ID: 7702795
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hemodynamic changes at rest and during exercise in long-term prazosin therapy for essential hypertension.
    Lund-Johansen P
    Postgrad Med; 1975 Nov; Spec No():45-52. PubMed ID: 1197143
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Evaluation of the hypotensive effect of captopril in patients with severe and treatment-resistant arterial hypertension].
    Grajek S; Paradowski S; Kozłowska F; Gracz M
    Kardiol Pol; 1988; 31(8):515-22. PubMed ID: 3072437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.